Pro Medicus' U.S. subsidiary Visage Imaging has extended its contract with The Ohio State University Wexner Medical Center for five years, adding new Visage 7 modules and increasing transaction fees, underpinning strong client retention and platform demand.
- Five-year A$16 million contract renewal
- Inclusion of Visage 7 Workflow and Cardiology Imaging
- Transaction-based model with higher minimums and fees
- Part of A$141 million total renewals this financial year
- Strengthens Visage 7 Enterprise Imaging Platform footprint
Significant Renewal Boosts Pro Medicus US Revenue Base
Pro Medicus Limited (ASX:PME) has reinforced its presence in the U.S. healthcare imaging market with a five-year, A$16 million contract renewal from The Ohio State University Wexner Medical Center (OSUWMC). The deal not only extends the existing relationship but also incorporates new Visage 7 Workflow and Visage 7 Cardiology Imaging modules, signalling growing adoption of the company's advanced imaging solutions.
Expanded Scope Reflects Platform Confidence
OSUWMC, a major academic medical center with over 22,000 staff and 1,400 inpatient beds, has increased its commitment under a transaction-based pricing model that now includes higher minimum usage thresholds and elevated fees per transaction. This suggests rising imaging volumes and deepening integration of Pro Medicus’ Visage 7 Enterprise Imaging Platform within the center’s clinical workflows.
Dr Sam Hupert, CEO of Pro Medicus, emphasised that the renewal validates the company’s native capabilities and customer appreciation for retiring legacy systems in favour of Visage’s scalable platform. The addition of cardiology imaging highlights the platform’s expanding clinical reach beyond traditional radiology applications.
Renewals Cement Strong Client Retention
This contract contributes to a cumulative A$141 million in renewals secured by Pro Medicus so far this financial year, underpinning a robust track record of client retention. The company’s ability to negotiate increased minimums and fees per transaction across major contracts, including this renewal, points to sustained demand and confidence in its technology suite.
Pro Medicus’ Visage 7 platform continues to gain traction as a cloud-deployable, clinically rich solution that addresses both financial and operational imperatives for large healthcare providers. The Ohio State deal complements recent major contracts with other US health systems, reinforcing the company’s expanding footprint in North America’s competitive medical imaging market.
Bottom Line?
The Ohio State renewal strengthens Pro Medicus’ recurring revenue and highlights growing clinical adoption of its Visage 7 platform, setting a solid foundation for continued US growth.
Questions in the middle?
- How will the integration of Visage 7 Cardiology Imaging impact OSUWMC’s clinical workflows?
- Can Pro Medicus maintain or increase transaction fees in future renewals as usage scales?
- What role will AI and workflow enhancements play in driving further contract expansions?